Contract Periods: Run-in and run-out provisions

Contract periods indicate for what start date and end date claims will be paid. If you are renewing a current policy, this should be fairly easy. As the first contract ends, the new contract picks up where the first left off without any lapse in coverage or complication around payment responsibility.

However, if you are changing policies or policy holders, you will want to read the fine print on both policies. What will happen if a claim occurs during the first policy’s effective dates but is not billed until the second policy’s effective dates? Without proper planning you may not have anyone to turn to pay that bill.

To solve this problem, run-in contracts and run-out contracts are available. Essentially you can create some overlap between your previous and new policy to cover any claims incurred in the few months surrounding your contract change date.

For example, if a new policy goes into effect on January 1, but a claim was incurred on December 20 of the prior year, there’s a good chance that the paperwork won’t be processed or billed until after the January 1 policy start date. With a one year policy, your company would likely have to pay the bill. With a run-in policy, the insurance company would pay the bill. Three months of overlap in incurred/billed dates is the standard.
The most common contract periods are:

  • 12/12 – Claims are covered only when the services are incurred and the claims billed within the policy year. This is a common contract length for the first year a company is self-funding.
  • 15/12 or “run-in policy” – Claims are covered when services are incurred three months before the policy start date and all those within the policy year.
  • 12/15 or “run-out” policy – Claims are covered when services are incurred within the policy year and paid within three months after the end of the policy year. Other common run-out periods are 12/18 and 12/24.

Finally, when negotiating your new contract, be sure to also look at the catastrophic and high value claims section. Since these claim types are becoming more common, caps will likely be put in place as a ceiling on the liability the insurance is willing to pay. You should know what these are before signing a new contract.


Contact Block (Blog)

Recent Comments

    Newsletter Signup

    Signup to start receiving the latest newsletters from StopLoss right to your email.
    Stay up to date on insurance trends and insights.

    Back to Top

    In 2011, the top 5 most expensive medical conditions treated in US hospitals were: Septicemia, Osteoarthritis, Complication of device, implant or graft, Liveborn, and Acute myocardial infarction

    From 2010 to 2013, the number of claims that were individually $1 million or above rose by 1,000%

    In 2017 approximately 18% of the American public will purchase insurance through exchanges, radically transforming the health insurance landscape.

    In 2014, 98% of large firms (= 200 Workers) offer 1+ wellness programs to their employees.

    The most costly 1% of patients account for 20% of national health expenditures – accruing average annual expenses of nearly $90,000 per person.

    6% of firms offering fully-insured plans report they intend to self-insure because of Obamacare.

    In 2014, PPO plans remained the most common plan type, enrolling 58% of covered workers.

    In 2012, 93% of businesses with 5,000+ employees and 80% of companies with 1,000-4,999 employees were self-funded

    Massachusetts has the third-highest prevalence of self-funded insurance in the small-group market (Fewer than 50 employees).

    In 2013, the average deductible was $2,906 for individuals selecting plans from marketplaces. This compares with average deductibles of $1,135 for an individual with employer coverage.

    In 2013, the average annual premiums for employer-sponsored health insurance are $5,884 for single coverage and $16,351 for family coverage, up 5% and 4% respectively from 2012.

    From 2010 – 2013, cancer followed by chronic/end stage renal disease and leukemia accounted for the top 3 costliest illnesses.